International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(24), С. 13666 - 13666
Опубликована: Дек. 20, 2024
Urologic
cancers
exhibit
tumor
heterogeneity
in
their
morphology,
gene
expression,
and
phenotypic
features,
have
different
responses
to
drug
treatment
[...]
PeerJ,
Год журнала:
2025,
Номер
13, С. e18995 - e18995
Опубликована: Апрель 8, 2025
Bladder
cancer
(BC)
represents
a
life-threatening
malignancy
within
the
urinary
system.
Dysregulated
long
non-coding
RNAs
(lncRNAs)
play
pivotal
roles
in
advancement
of
BC.
LncRNA
deleted
lymphocytic
leukemia
2
(DLEU2)
is
implicated
development
various
cancers.
However,
its
role
and
regulatory
mechanisms
BC
remain
unclear.
This
research
aimed
to
explore
expression,
biological
function,
molecular
DLEU2
In
progression.
Expression
profiles
lncRNAs,
microRNAs
(miRNAs),
mRNAs
normal
tissues
were
examined
by
leveraging
raw
data
sourced
from
NCBI
GEO
database.
Reverse
transcription
quantitative
polymerase
chain
reaction
(RT-qPCR)
validated
expression
levels
cells.
To
evaluate
proliferation
migration
capabilities
cells,
assays
such
as
CCK-8,
EdU,
Transwell,
scratch
carried
out.
Luciferase
reporter
interactions
between
miR-103a-2-5p
with
SOS1.
Protein
SOS1
cells
was
analyzed
via
western
blotting.
markedly
increased
tissues.
Functionally,
overexpression
elevated
cell
migration,
while
knockdown
produced
opposite
effects.
Mechanistically,
acted
sponge
for
miR-103a-2-5p,
which
targeted
enhanced
co-knockdown
reversed
these
Overexpression
also
promoted
counteracted
overexpression.
Conversely,
inhibited
processes,
reversing
this
inhibition.
These
findings
demonstrate
that
facilitates
progression
miR-103a-2-5p/SOS1
axis.
study
reveals
novel
mechanism
underlying
highlights
potential
therapeutic
target
treatment.
Applied Organometallic Chemistry,
Год журнала:
2025,
Номер
39(6)
Опубликована: Май 21, 2025
ABSTRACT
The
mTOR
signaling
pathway
has
a
main
role
in
integrating
extracellular
and
intracellular
signals,
acting
as
key
regulator
of
proliferation,
growth,
metabolism,
survival.
Research
conducted
over
the
past
10
years
revealed
that
is
activated
numerous
cellular
processes,
including
angiogenesis,
tumor
formation,
adipogenesis,
insulin
resistance,
T‐lymphocyte
activation.
Furthermore,
it
dysregulated
various
human
diseases,
type
2
diabetes
cancer.
Recently,
nanoparticles
(NPs)
have
been
formulated
for
cancer
treatment.
Treatment
several
cancers
such
uterine
cancer,
lung
gastric
bone
glioma
reported
by
silver
NPs
green‐synthesized
plant
extracts.
This
study
reports
on
green
manufacture
utilizing
Panax
ginseng
its
antibladder
properties
follow
PI3K‐Akt‐mTOR
pathway.
were
described
using
UV‐Vis,
XRD,
FE‐SEM,
FT‐IR.
biological
aspects
focus
recent
study.
MTT
examination
was
used
to
evaluate
cytotoxic
potentials
Ag
HUVEC
TCCSUP
cells
after
exposed
them
48
h.
with
spherical
shape
an
appropriate
average
size
43.71
nm
shown
crystallinity
structure
results.
When
NPs,
cell's
viability
diminished,
resulting
IC
50
value
154
μg/mL.
An
in‐depth
indicated
influence
apoptosis
cell
proliferation
through
modulation.
Additionally,
antioxidant
evaluation
showed
NPs'
regarding
DPPH
62
inhibited
cycle
induced
triggered
NPs.
Therefore,
treatment
bladder
carcinoma,
may
prove
be
beneficial
natural
anticancer
agent.
Biomedicines,
Год журнала:
2024,
Номер
12(3), С. 647 - 647
Опубликована: Март 14, 2024
This
research
explores
the
therapeutic
efficacy
of
Darunavir
(DRV),
Rilpivirine
(RPV),
and
Etravirine
(ETV)
against
UM-UC-5
bladder
cancer
cells,
addressing
critical
need
for
innovative
treatments
in
research.
Through
a
comprehensive
assessment
their
individual
combined
effects
across
diverse
time
intervals,
ETV
emerges
as
most
potent
drug,
with
lowest
IC50
5.9
µM,
closely
followed
by
RPV
(lowest
9.6
µM),
while
DRV
exhibits
least
effectiveness
25.6
µM).
Notably,
significant
synergistic
effect
is
evident
combination,
especially
at
48
72
h
low
concentrations.
Synergies
are
also
observed
DRV,
albeit
to
lesser
extent
primarily
h.
Conversely,
combination
yields
minimal
effects,
predominantly
additive
nature.
In
summary,
this
pre-clinical
investigation
underscores
promising
potential
RPV,
both
standalone
hinting
repurposing
opportunities
therapy,
which
could
give
new
treatment
method
disease
that
faster
without
severe
side
anticancer
drugs.
These
findings
represent
substantial
stride
advancing
personalized
medicine
within
will
be
further
scrutinized
forthcoming
studies.
Diagnostics,
Год журнала:
2024,
Номер
14(22), С. 2501 - 2501
Опубликована: Ноя. 8, 2024
Bladder
cancer
(BC)
is
a
highly
heterogeneous
disease,
presenting
clinical
challenges,
particularly
in
predicting
patient
outcomes
and
selecting
effective
treatments.
Molecular
subtyping
has
emerged
as
an
essential
tool
for
understanding
the
biological
diversity
of
BC;
however,
its
implementation
practice
remains
limited
due
to
high
costs
complexity
genomic
techniques.
This
review
examines
role
immunohistochemistry
(IHC)
surrogate
marker
molecular
BC,
highlighting
potential
bridge
gap
between
advanced
classifications
routine
application;
Methods:
We
explore
evolution
taxonomic
classification
with
particular
focus
on
cytokeratin
(KRT)
expression
patterns
normal
urothelium,
which
are
key
identifying
basal
luminal
subtypes.
Furthermore,
we
emphasise
need
consensus
IHC
markers
reliably
define
these
subtypes,
facilitating
wider
standardised
use.
The
also
analyses
application
both
muscle-invasive
(MIBC)
non-muscle-invasive
bladder
(NMIBC),
attention
less
extensively
studied
NMIBC
cases.
discuss
practical
advantages
subtyping,
including
cost
effectiveness
feasibility
standard
pathology
laboratories,
alongside
ongoing
challenges
such
requirement
protocols
external
validation
across
diverse
settings;
Conclusions:
While
limitations,
it
offers
viable
alternative
laboratories
lacking
access
Further
research
required
determine
optimal
combination
markers,
establish
diagnostic
algorithm,
validate
through
large-scale
trials.
will
ultimately
enhance
accuracy,
guide
treatment
decisions,
improve
outcomes.
Medical Science Monitor,
Год журнала:
2024,
Номер
30
Опубликована: Июль 5, 2024
BACKGROUND
Bladder
cancer
(BC)
is
a
common
disease
worldwide.
Low
survival
rates
and
high
recurrence
lead
to
the
risk
of
mental
disorders.
This
study
analyzed
219
patients
with
bladder
using
Indonesian
Version
21-item
Depression,
Anxiety,
Stress
Scale
(DASS-21)
related
factors.
MATERIAL
AND
METHODS
cross-sectional
included
diagnosed
during
2019-2023
in
referral
hospital
Indonesia.
Data
were
collected
questionnaire
that
assessed
characteristics
DASS-21
questionnaire.
RESULTS
Some
caregivers
experienced
depression,
stress,
anxiety.
The
percentage
who
anxiety
was
higher
than
for
(47.9%
vs
45.7%).
Statistical
analysis
showed
age,
income,
marital
status
associated
incidence
depression
(p=0.000,
p=0.001,
p=0.000,
respectively),
p=0.012,
stress
p=0.007,
respectively).
Routes
patient
admission
(p=0.043,
respectively)
employment
(p=0.005,
Employment
also
(p=0.038,
found
routes
among
(p=0.036
CONCLUSIONS
Monitoring
providing
support
are
needed
prevent
poor
prognosis
due
psychological
problems,
including
paying
attention
sociodemographic
Современные проблемы науки и образования (Modern Problems of Science and Education),
Год журнала:
2024,
Номер
№4 2024, С. 22 - 22
Опубликована: Янв. 1, 2024
СОДЕРЖАНИЕ
ДОФАМИНА,
НОРАДРЕНАЛИНА,
СЕРОТОНИНА
И
5-ОКСИИНДОЛУКСУСНОЙ
КИСЛОТЫ
В
МОЧЕ
БОЛЬНЫХ
РАКОМ
МОЧЕВОГО
ПУЗЫРЯ
ЗАВИСИМОСТИ
ОТ
НАЛИЧИЯ
САХАРНОГО
ДИАБЕТАГорошинская
И.А